Celebrex Vioxx News

home   >   completeRSS

BioDelivery Sciences International Inc. said Tuesday that animal tests showed its Bioral drug coating may reduce gastrointestinal damage associated with aspirin and traditional anti-inflammatory drugs, potentially creating a new treatment option for patients...

- link to Celebrex Vioxx News -
Last update: 05/26/2005

Recommended Reading

    After withdrawal of Vioxx, two COX-2 agents remain: rofecoxib linked to thrombotic events.(News) : An article from: Internal Medicine News
    Merck should survive the bitter pill of Vioxx.(Merck and Company Inc.) : An article from: Business Record (Des Moines)
    Merck should survive the bitter pill of Vioxx.(Merck and Company Inc.) : An article from: Business Record (Des Moines)
    FDA's Vioxx move could hinder local biotech firms.(Food and Drug Administration) : An article from: San Diego Business Journal
    Seguridad para pacientes con artritis.(retirada del mercado del medicamento Vioxx; alternativas para el tratamiento de la artritis) : An article from: Siempre!
    Seguridad para pacientes con artritis.(retirada del mercado del medicamento Vioxx; alternativas para el tratamiento de la artritis) : An article from: Siempre!
    More data fail to resolve issue of COX-2 class effect: little information on long-term outcomes.(News)(Vioxx, Celebrex) : An article from: Family Practice News
    More data fail to resolve issue of COX-2 class effect: little information on long-term outcomes.(News)(Vioxx, Celebrex) : An article from: Family Practice News